SHMPFishing, Hunting and TrappingIFRS · EUR

NaturalShrimp Inc

NaturalShrimp Inc. is a Nevada corporation built around proprietary aquaculture technology designed to grow shrimp in controlled water systems, with roots in the acquisition of NaturalShrimp Holdings in 2015. Its business has historically combined shrimp farming, shrimp commercialization, and related intellectual property, while its current corporate direction also encompasses aquaculture and water-treatment technologies.

Kysy yhtiöstä
Liikevaihto0,2milj. EUR
+0,0 %v/v
Liikevoitto (EBIT)−6,9milj. EUR
+0,0 %v/v
EBIT-marginaali−3 412,7%
+0,0 %-yks.v/v
Nettotulos−10,7milj. EUR
+0,0 %v/v

Tilikausi 2026 · muutos edellisvuodesta

Kehitys 2021–2026

−60−40−20020milj. EUR2021: 0,00 milj. EUR2021: EBIT −3,3 milj. EUR20212022: 0,03 milj. EUR2022: EBIT −54 milj. EUR20222023: 0,24 milj. EUR2023: EBIT −11 milj. EUR20232024: 0,45 milj. EUR2024: EBIT −11 milj. EUR20242025: 0,20 milj. EUR2025: EBIT −6,9 milj. EUR20252026: 0,20 milj. EUR2026: EBIT −6,9 milj. EUR20260,20−6,9
LiikevaihtoLiikevoitto (EBIT)
Kysy Clarifolta: NaturalShrimp Inc

Liiketoiminta

Osuus liikevaihdosta
Shrimp aquaculture systems45 %

Technology and infrastructure for growing shrimp in controlled water environments.

Shrimp production25 %

Cultivation and potential sale of shrimp produced through company-developed systems.

Water-treatment technology20 %

Water treatment and quality-control technologies supporting aquaculture and other applications.

Intellectual property and licensing10 %

Patents, license agreements, and related rights connected with aquaculture technologies.

Tuotteet

Raportoitu · osuus liikevaihdosta
67,2%32,8%FY2024100 %
  • Technology and Equipment Services67,2 %
  • Shrimp Sales32,8 %

Lähde: 10-K FY2024, yhtiön tuotelinjoittain raportoima liikevaihto (SEC XBRL). Osuudet on laskettu näytetyistä riveistä ja ne summautuvat 100 %:iin.

Asiakkaat

The company’s historical commercial customers were expected to include seafood distributors, food-service operators, retailers, and other buyers of farmed shrimp. Technology-oriented customers and partners may include aquaculture operators, water-treatment users, and licensees seeking controlled production systems or water-quality solutions. The available report does not disclose named customers, customer concentration, or revenue by customer type.

Seafood distributors

Potential buyers of farmed shrimp for wholesale distribution and downstream food markets.

Retail and food service

Potential end-market buyers seeking domestic or controlled-environment shrimp supply.

Aquaculture operators

Potential users or licensees of controlled shrimp-production systems and operating know-how.

Water-treatment customers

Potential commercial users of water-quality and treatment technologies developed for aquaculture applications.

Strategia

The company’s strategic direction is centered on commercializing aquaculture and water-treatment technologies under its March 2026 Intellectual Property and Management Transition Agreement with Hydrenesis and David Antelo. This direction follows the transfer of substantially all historical operating assets, patents, and license agreements to lenders in May 2025, making technology commercialization and corporate transition central to any future business model.

Commercialize aquaculture and water-treatment technologiesKeskipitkä aikaväli

Technology commercialization is the stated basis for the company’s post-transition direction.

Complete governance and management transitionLyhyt aikaväli

Operational control transferred under the Intellectual Property and Management Transition Agreement.

Rebuild an operating business around intellectual propertyKeskipitkä aikaväli

Historical fixed assets and intellectual property were transferred in the lender asset sale.

Maantiede

NaturalShrimp is incorporated in Nevada and developed its business as a U.S.-based shrimp-farming technology company with ambitions for global commercialization. The available report does not provide country-level revenue, operating-site revenue, or regional revenue percentages. Geographic exposure therefore relates primarily to U.S. corporate, financing, legal, and technology-commercialization activities rather than a disclosed international revenue base.

Riskit

NaturalShrimp faces unusually high execution and continuity risk because a receiver sold substantially all operating assets to lenders, the company ceased business operations as of the May 2025 transfer, and its shares trade only on the OTC Expert Market. Future value depends on successfully commercializing technologies, clarifying control and asset rights, and securing customers or partners in aquaculture and water treatment. Industry risks include biological production failures, disease, water-quality problems, regulatory requirements, capital intensity, and competition from established aquaculture and treatment providers.

Järjestetty vakavuuden mukaan
Loss of operating assetsKriittinen

Substantially all fixed assets, patents, and license agreements were transferred to lenders in May 2025.

Kohdistuu: Future operations may depend on rights obtained through transition arrangements.

Business continuity and executionKriittinen

The company ceased business operations after the asset transfer and must establish a viable post-transition model.

Kohdistuu: Aquaculture and water-treatment commercialization.

Receivership and legal claimsKorkea

Lenders obtained court-appointed receivership after alleged defaults under loan agreements.

KohdistuuCorporate assetsCreditor prioritiesOwnership rights
Aquaculture production riskKorkea

Shrimp production can be disrupted by disease, mortality, water-quality failures, and system outages.

Kohdistuu: Controlled-environment farming operations.

Commercialization and funding riskKorkea

Technology deployment requires customers, partners, regulatory approvals, and capital.

Kohdistuu: Future revenue generation and operating scale.

Trading and investor-access riskKorkea

The stock is eligible only for unsolicited broker quotations on the OTC Expert Market.

KohdistuuShare liquidityPrice discoveryAccess to capital
Kysy Clarifolta: NaturalShrimp Inc

Kirjanpito

Harkinnanvaraiset erät
Liquidation basis of accounting

ASC 205-30 applies when liquidation is imminent and changes asset, liability, and cost measurement.

Vaikutus: Reported balances emphasize estimated liquidation proceeds and settlement obligations rather than continuing operations.

Asset derecognition

Fixed assets, patents, and license agreements were transferred to lenders in May 2025.

Vaikutus: The transaction removed significant operating assets and intangible assets from the balance sheet.

Debt extinguishment

Outstanding obligations to Streeterville and Buckstown were settled through the asset transfer.

Vaikutus: Approximately $36 million of lender liabilities were extinguished, affecting net assets and period results.

Estimates of liquidation proceeds and costs

Liquidation accounting requires estimates of expected asset recoveries, settlement amounts, and costs through liquidation.

Vaikutus: Changes in valuation assumptions can materially affect reported net assets and results.

Samankaltaisia listattuja yhtiöitä

Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.

Trans American Aquaculture, Inc

GRPS · Agricultural Prod-Livestock & Animal Specialties

Megan Holdings Ltd.

MGN · Agricultural Prod-Livestock & Animal Specialties

NanoViricides, Inc

NNVC · Pharmaceutical Preparations

Natural Alternatives International, Inc

NAII · Medicinal Chemicals & Botanical Products

Farmhouse, Inc. /NV

FMHS · Services-Computer Programming, Data Processing, Etc.

Nature's Miracle Holding Inc.

NMHIW · Farm Machinery & Equipment

Päivitetty: 8.9.2026

NaturalShrimp Inc – Fishing, Hunting and Trapping | Analyysi – Clarifo